Bosch and Randox: Strategic partnership brings highly multiplexing PCR to the point of care / BioMEMS technology enables fully automated, simultaneous testing for hundreds of genetic characteristics in just a few minutes
Wednesday 10 April, 2024
Bosch and Randox Laboratories Ltd. enter partnership for Vivalytic
analysis platform to jointly invest around 150 million euros.
First test to feature novel BioMEMS technology will be a highly
multiplexing sepsis IVD grade test.
Wiblingen - Bosch has agreed on a strategic partnership with Randox Laboratories
Ltd., a leading diagnostic and medical technology company. The two
... Читать дальше...